AL002 is an mAb binding to TREM2, activating microglia and Aβ phagocytosis and shown to ameliorate AD in a mouse model; in humans, AL002 has been shown to be safe and well tolerated, engaging TREM2 based on cerebrospinal fluid biomarkers [184]. This evidence concerns the gene TREM2 and Alzheimer disease.